Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVela Technologies Regulatory News (VELA)

  • There is currently no data for VELA

Update re. AZD1656

9 Nov 2022 09:00

RNS Number : 8188F
Vela Technologies PLC
09 November 2022
 

9 November 2022

Vela Technologies plc

("Vela" or "the Company")

Update re. AZD1656

The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, notes the announcement made yesterday evening by Conduit Pharmaceuticals Limited ("Conduit") that it intends to become a publicly traded company on NASDAQ in the USA via a merger with Murphy Cannon Acquisition Corp. ("Murphy"), a NASDAQ-listed special purpose acquisition company.

 

Vela holds an economic interest in the commercialisation of a particular application of AZD1656, one of the assets of Conduit. Details of Vela's interest in AZD1656 were set out in the announcement published by Vela on 20 October 2020.

A copy of the announcement can be found at:

Conduit Pharmaceuticals to Become a Publicly Traded Company via Merger with Murphy Canyon Acquisition Corp. (accesswire.com)

 

The salient points of the announcement are as follows:

· Conduit and Murphy have entered into a definitive business combination agreement.

· The business combination is expected to provide Conduit with access to the public equity markets, which the parties believe will accelerate development of Conduit's autoimmune disease and idiopathic male infertility pipeline.

· The business combination is expected to close in the first quarter of 2023.

· The transaction is expected to deliver cash proceeds of around $149.65 million to Conduit (assuming no redemptions) to fund Conduit's clinical development programmes.

Further information on Conduit, including details on its relationship and partnership with St. George Street Capital, can be found in this presentation which was published as an SEC filing yesterday evening: https://www.sec.gov/Archives/edgar/data/1896212/000149315222030986/ex99-2.htm

For further information, please contact:

Vela Technologies plc

 

Brent Fitzpatrick, Non-Executive Chairman

James Normand, Executive Director

Tel: +44 (0) 7410886830

Allenby Capital Limited (Nominated Adviser)

Tel: +44 (0) 20 3328 5656

Nick Athanas / Piers Shimwell

Peterhouse Capital Limited (Broker)

Tel: +44 (0) 20 7469 0930

Lucy Williams / Duncan Vasey / Eran Zucker / Lauren Riley

Novus Communications (PR and IR Adviser)

Tel: +44 (0) 20 7448 9839

Alan Green / Jacqueline Briscoe

About Vela Technologies

Vela Technologies plc (AIM: VELA) is an investing company focused on early stage and pre-IPO long term disruptive technology investments.   Vela's investee companies have either developed ways of utilising technology or are developing technology with a view to disrupting the businesses or sector in which they operate. Vela Technologies will also invest in already-listed companies where valuations offer additional opportunities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDVKLBBLFLEFBD
Date   Source Headline
29th Sep 20067:02 amRNSChange of Adviser
27th Sep 20067:02 amRNSInterim Results
13th Sep 20067:02 amRNSNotice of Results
12th Jul 20061:20 pmRNSStmnt re Share Price Movement
20th Jun 20067:00 amRNSDirectorate Change
6th Jun 20063:26 pmRNSAGM and Directorate Changes
11th May 20062:19 pmRNSRule 8.3- Deal Group Media
10th May 20063:48 pmRNSRule 8.3- Deal Group Media
8th May 20062:52 pmRNSRule 8.3-Deal Group Media Plc
13th Mar 20067:01 amRNSFinal Results
9th Mar 20061:12 pmRNSRule 8.3-Deal Group Media PLC
1st Mar 20061:27 pmRNSRule 8.3- Deal Group Media
21st Feb 20062:20 pmRNSRule 8.3-Deal Group Media PLC
21st Feb 20067:01 amRNSNotice of Results
14th Feb 20063:09 pmRNSStmt re Possible Offer-Amend
13th Feb 20064:27 pmRNSRule 2.10 Announcement
13th Feb 20061:22 pmRNSStatement re Possible Offer
19th Jan 20069:59 amRNSDirector Shareholding
18th Jan 20067:00 amRNSAppointment of COO
9th Jan 20069:53 amRNSAdditional Listing
20th Dec 200512:15 pmRNSHolding(s) in Company
23rd Nov 20051:58 pmRNSHolding(s) in Company
22nd Nov 200510:34 amRNSHolding(s) in Company
21st Nov 20053:10 pmRNSDirectorate Change
21st Nov 20053:06 pmRNSTrading Statement
15th Nov 20057:01 amRNSHolding(s) in Company
11th Nov 20059:14 amRNSHolding(s) in Company
27th Oct 20057:00 amRNSAdditional Listing
26th Oct 20054:18 pmRNSHolding(s) in Company
7th Oct 200512:39 pmRNSDirector/PDMR Shareholding
30th Sep 200511:40 amRNSDirector Shareholding
30th Sep 200510:44 amRNSDirector Shareholding
29th Sep 20058:34 amRNSDirector Shareholding
28th Sep 200512:55 pmRNSDirector Shareholding
27th Sep 20053:57 pmRNSDirector Shareholding
26th Sep 200512:56 pmRNSHolding(s) in Company
23rd Sep 20052:45 pmRNSTrading Statement
21st Sep 20055:24 pmRNSHolding(s) in Company
16th Sep 20052:46 pmRNSHolding(s) in Company
15th Sep 20053:48 pmRNSHolding(s) in Company
6th Sep 20057:01 amRNSInterim Results
19th Aug 20057:00 amRNSAdditional Listing
5th Aug 20059:30 amRNSNotice of Results
18th Jul 20055:00 pmRNSAdditional Listing
18th May 20055:11 pmRNSDirector Shareholding
18th May 200512:45 pmRNSDirector Shareholding
17th May 20052:47 pmRNSAdditional Listing
14th Apr 20055:02 pmRNSDirectors Shareholdings
14th Apr 200511:39 amRNSAdditional Listing
29th Mar 20057:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.